Patient Access Liaison - Mountain
Intellia Therapeutics
About this role
Intellia Therapeutics is recruiting a field-based Patient Access Liaison to support the commercialization of lonvo‑z, an in vivo one‑time CRISPR therapy. The role sits within the patient access organization and supports efforts to ensure patient treatment access during the product launch. This position contributes to Intellia’s mission to develop curative genome editing treatments.
Skills
Qualifications
About Intellia Therapeutics
intelliatx.comIntellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
Recent company news
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
3 days ago
Is Intellia Therapeutics (NTLA) Pricing Look Interesting After Strong Year-To-Date Share Gain?
13 hours ago
Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory
5 days ago
FDA ends trial halt on 1,200-patient heart disease study
3 days ago
Intellia gets FDA nod to resume second gene therapy trial after safety pause
3 days ago
About Intellia Therapeutics
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Intellia Therapeutics.
Salary
$194k – $237k
per year
More jobs at Intellia Therapeutics
Similar Jobs
Associate Director, Market Access & Reimbursement- Buckeye
Sarepta Therapeutics
Associate Director, Market Access & Reimbursement- Southeast
Sarepta Therapeutics
Associate Director, Access & Reimbursement
Nuvalent, Inc.
Patient Access Liaison
Amgen
MGT Patient Access Coordinator - East
Pfizer
Associate Director, Market Access & Reimbursement- Southeast
Sarepta Therapeutics